{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:25:18Z","timestamp":1784031918553,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fogarty International Center at the U.S. National Institutes of Health","award":["R25TW009343"],"award-info":[{"award-number":["R25TW009343"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer is the fourth most common cancer among women with significant global disparities in disease burden. In lower-resource settings, where routine screening for cervical cancer is uncommon, higher incidence of advanced-stage disease contributes to increased morbidity and mortality. Understanding care delays may inform strategies to decrease overall time to treatment, and could potentially improve outcomes. We sought to characterize the cervical cancer care cascade and identify factors associated with time to care cascade completion within a Ugandan cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected sociodemographic, reproductive health and care journey data from 268 Ugandan women newly diagnosed with cervical cancer at Mulago National Referral Hospital and the Uganda Cancer Institute. We characterized time from symptoms to presentation (patient interval), time from presentation to diagnosis (diagnostic interval) and time from diagnosis to treatment (treatment interval) and estimated the influence of patient, health provider, system, and disease factors on length of each interval using survival analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median patient, diagnostic and treatment intervals were 74 days (IQR 26\u2013238), 83 days (IQR 34\u2013229), and 34 days (IQR 18\u201358), respectively. Patient interval was prolonged by the belief that symptoms would resolve spontaneously (aHR 0.37, 95% CI 0.24\u20130.57), confusion about where to seek care (aHR 0.64, 95% CI 0.47\u20130.88), and utilization of traditional care (aHR 0.70, 95% CI 0.51\u20130.96). Patient interval facilitators included perceiving symptoms as serious (aHR 2.14, 95% CI 1.43\u20133.19) and suspecting cancer (aHR 1.82, 95% CI 1.12\u20132.97). Diagnostic interval delays included symptomatic bleeding (aHR 055, 95% CI 0.35\u20130.85) and visiting\u2009&gt;\u20092 clinics (aHR 0.69, 95% CI 0.49\u20130.97); facilitators included early-stage disease (aHR 1.41, 95% CI 1.03\u20131.95) and direct tertiary care presentation (aHR 2.13, 95% CI 1.20\u20133.79). Treatment interval delays included anticipating long waits (aHR 0.68, 95% CI 0.46\u20131.02) and requiring blood transfusions (aHR 0.63, 95% CI 0.37\u20131.07); no facilitators were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified potentially modifiable barriers and facilitators along the cervical cancer care cascade. Interventions targeting these factors may reduce delays, but are unlikely to significantly improve morbidity or mortality given advanced-stage disease at symptom acknowledgement and relatively timely treatment initiation. Expanding cervical cancer screening and vaccination are of utmost importance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-026-04292-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:33:58Z","timestamp":1770957238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of delay in the cervical cancer care cascade in Kampala, Uganda"],"prefix":"10.1186","volume":"26","author":[{"given":"Megan","family":"Swanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"El Ayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Nakalembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Namugga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nakisige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-may","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Huchko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"6","key":"4292_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4292_CR2","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197\u2013206.","journal-title":"Lancet Glob Health"},{"key":"4292_CR3","unstructured":"Bruni L B-RL, Albero G, Aldea M, Serrano B, Valencia S, Brotons M, Mena M, Cosano R, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S, Castellsagu\u00e9 X. Human Papillomavirus and Related Diseases in Uganda. Summary Report 2016\u201302\u201326. ICO Information Centre on HPV and Cancer (HPV Information Centre); 2016."},{"key":"4292_CR4","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2024.1782","volume":"18","author":"F Okongo","year":"2024","unstructured":"Okongo F, Amuge C, Jatho A, Niyonzima N, Ogwang DM, Orem J. The regional cancer spectrum in Uganda: a population-based cancer survey by sub-regions (2017\u20132020). Ecancermedicalscience. 2024;18:1782.","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"4292_CR5","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4292_CR6","doi-asserted-by":"publisher","first-page":"2253308","DOI":"10.1080\/01443615.2023.2253308","volume":"43","author":"R Kassa","year":"2023","unstructured":"Kassa R, Irene Y, Woldetsadik E, Kidane E, Higgins M, Dejene T, et al. Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis. J Obstet Gynaecol. 2023;43(2):2253308.","journal-title":"J Obstet Gynaecol"},{"key":"4292_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gore.2017.12.005","volume":"24","author":"M Swanson","year":"2018","unstructured":"Swanson M, Ueda S, Chen L-m, Huchko MJ, Nakisige C, Namugga J. Evidence-based improvisation: facing the challenges of cervical cancer care in Uganda. Gynecol Oncol Rep. 2018;24:30\u20135.","journal-title":"Gynecol Oncol Rep"},{"issue":"11","key":"4292_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1470-2045(15)00223-5","volume":"16","author":"R Sullivan","year":"2015","unstructured":"Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):1193\u2013224.","journal-title":"Lancet Oncol"},{"issue":"5","key":"4292_CR9","first-page":"653","volume":"20","author":"KM Robinson","year":"2011","unstructured":"Robinson KM, Christensen KB, Ottesen B, Krasnik A. Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer. Eur J Cancer Care. 2011;20(5):653\u201361.","journal-title":"Eur J Cancer Care"},{"key":"4292_CR10","first-page":"14","volume":"12","author":"M Berraho","year":"2012","unstructured":"Berraho M, Obtel M, Bendahhou K, Zidouh A, Errihani H, Benider A, et al. Sociodemographic factors and delay in the diagnosis of cervical cancer in Morocco. Pan Afr Med J. 2012;12:14.","journal-title":"Pan Afr Med J"},{"key":"4292_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-015-0231-0","volume":"15","author":"SK Tadesse","year":"2015","unstructured":"Tadesse SK. Socio-economic and cultural vulnerabilities to cervical cancer and challenges faced by patients attending care at Tikur Anbessa Hospital: a cross sectional and qualitative study. BMC Womens Health. 2015;15:75.","journal-title":"BMC Womens Health"},{"issue":"7","key":"4292_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/pon.3464","volume":"23","author":"LA Marlow","year":"2014","unstructured":"Marlow LA, McGregor LM, Nazroo JY, Wardle J. Facilitators and barriers to help-seeking for breast and cervical cancer symptoms: a qualitative study with an ethnically diverse sample in London. Psychooncology. 2014;23(7):749\u201357.","journal-title":"Psychooncology"},{"issue":"6","key":"4292_CR13","first-page":"729","volume":"25","author":"RI Anorlu","year":"2004","unstructured":"Anorlu RI, Orakwue CO, Oyeneyin L, Abudu OO. Late presentation of patients with cervical cancer to a tertiary hospital in Lagos: what is responsible? Eur J Gynaecol Oncol. 2004;25(6):729\u201332.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"627","key":"4292_CR14","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.3399\/bjgp14X681757","volume":"64","author":"AW Lim","year":"2014","unstructured":"Lim AW, Ramirez AJ, Hamilton W, Sasieni P, Patnick J, Forbes LJ. Delays in diagnosis of young females with symptomatic cervical cancer in England: an interview-based study. Br J Gen Pract. 2014;64(627):e602\u201310.","journal-title":"Br J Gen Pract"},{"key":"4292_CR15","doi-asserted-by":"crossref","unstructured":"Miller JW, Hanson V, Johnson GD, Royalty JE, Richardson LC. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2014;120 Suppl 16(0 16):2549\u201356.","DOI":"10.1002\/cncr.28823"},{"key":"4292_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087.","journal-title":"BMJ"},{"issue":"33","key":"4292_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004568","volume":"95","author":"SC Shen","year":"2016","unstructured":"Shen SC, Hung YC, Kung PT, Yang WH, Wang YH, Tsai WC. Factors involved in the delay of treatment initiation for cervical cancer patients: a nationwide population-based study. Medicine (Baltimore). 2016;95(33):e4568.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4292_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221946","volume":"14","author":"CP Chen","year":"2019","unstructured":"Chen CP, Kung PT, Wang YH, Tsai WC. Effect of time interval from diagnosis to treatment for cervical cancer on survival: a nationwide cohort study. PLoS ONE. 2019;14(9):e0221946.","journal-title":"PLoS ONE"},{"issue":"1","key":"4292_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007690","volume":"6","author":"AD Mwaka","year":"2016","unstructured":"Mwaka AD, Garimoi CO, Were EM, Roland M, Wabinga H, Lyratzopoulos G. Social, demographic and healthcare factors associated with stage at diagnosis of cervical cancer: cross-sectional study in a tertiary hospital in Northern Uganda. BMJ Open. 2016;6(1):e007690.","journal-title":"BMJ Open"},{"key":"4292_CR20","doi-asserted-by":"crossref","unstructured":"Ferreira da Silva I, Ferreira da Silva I, Koifman RJ. Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country. J Glob Oncol. 2019;5:1\u201311.","DOI":"10.1200\/JGO.18.00199"},{"key":"4292_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/hex.12382","author":"AD Mwaka","year":"2015","unstructured":"Mwaka AD, Orach CG, Were EM, Lyratzopoulos G, Wabinga H, Roland M. Awareness of cervical cancer risk factors and symptoms: cross-sectional community survey in post-conflict northern Uganda. Health Expect. 2015. https:\/\/doi.org\/10.1111\/hex.12382.","journal-title":"Health Expect"},{"key":"4292_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-14-84","volume":"14","author":"AD Mwaka","year":"2014","unstructured":"Mwaka AD, Okello ES, Kiguli J, Rutebemberwa E. Understanding cervical cancer: an exploration of lay perceptions, beliefs and knowledge about cervical cancer among the Acholi in northern Uganda. BMC Womens Health. 2014;14:84.","journal-title":"BMC Womens Health"},{"key":"4292_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-015-0167-4","volume":"15","author":"AD Mwaka","year":"2015","unstructured":"Mwaka AD, Okello ES, Wabinga H, Walter FM. Symptomatic presentation with cervical cancer in Uganda: a qualitative study assessing the pathways to diagnosis in a low-income country. BMC Womens Health. 2015;15:15.","journal-title":"BMC Womens Health"},{"key":"4292_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1475-9276-9-23","volume":"9","author":"JN Orem","year":"2010","unstructured":"Orem JN, Zikusooka CM. Health financing reform in Uganda: how equitable is the proposed National Health Insurance scheme? Int J Equity Health. 2010;9:23.","journal-title":"Int J Equity Health"},{"key":"4292_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijoa.2015.09.006","volume":"25","author":"JG Meara","year":"2016","unstructured":"Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Int J Obstet Anesth. 2016;25:75\u20138.","journal-title":"Int J Obstet Anesth"},{"issue":"3","key":"4292_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00268-009-0229-6","volume":"34","author":"G Dubowitz","year":"2010","unstructured":"Dubowitz G, Detlefs S, McQueen KA. Global anesthesia workforce crisis: a preliminary survey revealing shortages contributing to undesirable outcomes and unsafe practices. World J Surg. 2010;34(3):438\u201344.","journal-title":"World J Surg"},{"issue":"1","key":"4292_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1213\/ANE.0000000000001690","volume":"124","author":"I Epiu","year":"2017","unstructured":"Epiu I, Tindimwebwa JV, Mijumbi C, Chokwe TM, Lugazia E, Ndarugirire F, et al. Challenges of anesthesia in low- and middle-income countries: a cross-sectional survey of access to safe obstetric anesthesia in East Africa. Anesth Analg. 2017;124(1):290\u20139.","journal-title":"Anesth Analg"},{"issue":"3","key":"4292_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.transci.2013.06.014","volume":"49","author":"TC Lund","year":"2013","unstructured":"Lund TC, Hume H, Allain JP, McCullough J, Dzik W. The blood supply in sub-Saharan Africa: needs, challenges, and solutions. Transfus Apher Sci. 2013;49(3):416\u201321.","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"4292_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.surg.2013.10.008","volume":"155","author":"DG LeBrun","year":"2014","unstructured":"LeBrun DG, Chackungal S, Chao TE, Knowlton LM, Linden AF, Notrica MR, et al. Prioritizing essential surgery and safe anesthesia for the post-2015 development agenda: operative capacities of 78 district hospitals in 7 low- and middle-income countries. Surgery. 2014;155(3):365\u201373.","journal-title":"Surgery"},{"issue":"4","key":"4292_CR30","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S1470-2045(12)70532-6","volume":"14","author":"M Abdel-Wahab","year":"2013","unstructured":"Abdel-Wahab M, Bourque JM, Pynda Y, Izewska J, Van der Merwe D, Zubizarreta E, et al. Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol. 2013;14(4):e168\u201375.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4292_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijrobp.2014.03.002","volume":"89","author":"NR Datta","year":"2014","unstructured":"Datta NR, Samiei M, Bodis S. Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. Int J Radiat Oncol Biol Phys. 2014;89(3):448\u201357.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"4292_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039946","volume":"10","author":"M Swanson","year":"2020","unstructured":"Swanson M, Nakalembe M, Chen LM, Ueda S, Namugga J, Nakisige C, et al. Surgical candidacy and treatment initiation among women with cervical cancer at public referral hospitals in Kampala, Uganda: a descriptive cohort study. BMJ Open. 2020;10(12):e039946.","journal-title":"BMJ Open"},{"key":"4292_CR33","unstructured":"Zikusooka CM, Kyomuhang R, Orem JN, Tumwine M. Is health care financing in Uganda equitable? Afr Health Sci. 2009;9 Suppl 2(Suppl 2):S52\u20138."},{"issue":"27","key":"4292_CR34","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1200\/JCO.2016.68.3789","volume":"34","author":"LT Chuang","year":"2016","unstructured":"Chuang LT, Feldman S, Nakisige C, Temin S, Berek JS. Management and care of women with invasive cervical cancer: ASCO resource-stratified clinical practice guideline. J Clin Oncol. 2016;34(27):3354\u20135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4292_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1200\/JCO.2002.20.1.179","volume":"20","author":"P Benedetti-Panici","year":"2002","unstructured":"Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179\u201388.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4292_CR36","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1200\/JCO.2000.18.8.1740","volume":"18","author":"TC Chang","year":"2000","unstructured":"Chang TC, Lai CH, Hong JH, Hsueh S, Huang KG, Chou HH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol. 2000;18(8):1740\u20137.","journal-title":"J Clin Oncol"},{"key":"4292_CR37","doi-asserted-by":"crossref","unstructured":"Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst Rev. 2015(4):Cd010260.","DOI":"10.1002\/14651858.CD010260.pub2"},{"issue":"2","key":"4292_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1258\/jhsrp.2011.010113","volume":"17","author":"F Walter","year":"2012","unstructured":"Walter F, Webster A, Scott S, Emery J. The andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy. 2012;17(2):110\u20138.","journal-title":"J Health Serv Res Policy"},{"issue":"1","key":"4292_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.2044-8287.2012.02077.x","volume":"18","author":"SE Scott","year":"2013","unstructured":"Scott SE, Walter FM, Webster A, Sutton S, Emery J. The model of pathways to treatment: conceptualization and integration with existing theory. Br J Health Psychol. 2013;18(1):45\u201365.","journal-title":"Br J Health Psychol"},{"issue":"Pt 1","key":"4292_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.2044-8309.1995.tb01047.x","volume":"34","author":"BL Andersen","year":"1995","unstructured":"Andersen BL, Cacioppo JT. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol. 1995;34(Pt 1):33\u201352.","journal-title":"Br J Soc Psychol"},{"key":"4292_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-626","volume":"12","author":"K Unger-Saldana","year":"2012","unstructured":"Unger-Saldana K, Pelaez-Ballestas I, Infante-Castaneda C. Development and validation of a questionnaire to assess delay in treatment for breast cancer. BMC Cancer. 2012;12:626.","journal-title":"BMC Cancer"},{"issue":"4","key":"4292_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/bimj.201700090","volume":"60","author":"S Ahn","year":"2018","unstructured":"Ahn S, Lim J, Paik MC, Sacco RL, Elkind MS. Cox model with interval-censored covariate in cohort studies. Biom J. 2018;60(4):797\u2013814.","journal-title":"Biom J"},{"issue":"1","key":"4292_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0962280209105023","volume":"19","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Sun J. Interval censoring. Stat Methods Med Res. 2010;19(1):53\u201370.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"4292_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/sj.bjc.6601034","volume":"89","author":"H Wabinga","year":"2003","unstructured":"Wabinga H, Ramanakumar AV, Banura C, Luwaga A, Nambooze S, Parkin DM. Survival of cervix cancer patients in Kampala, Uganda: 1995\u20131997. Br J Cancer. 2003;89(1):65\u20139.","journal-title":"Br J Cancer"},{"issue":"1","key":"4292_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-6065-6","volume":"18","author":"P Dunyo","year":"2018","unstructured":"Dunyo P, Effah K, Udofia EA. Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study. BMC Public Health. 2018;18(1):1156.","journal-title":"BMC Public Health"},{"key":"4292_CR46","first-page":"1","volume":"4","author":"PH Park","year":"2018","unstructured":"Park PH, Davey S, Fehr AE, Butonzi J, Shyirambere C, Hategekimana V, et al. Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda. J Glob Oncol. 2018;4:1\u201311.","journal-title":"J Glob Oncol"},{"issue":"2","key":"4292_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2021.12.002","volume":"164","author":"RJ DeBoer","year":"2022","unstructured":"DeBoer RJ, Umutoni V, Bazzett-Matabele L, Katznelson E, Nguyen C, Umwizerwa A, et al. Cervical cancer treatment in Rwanda: resource-driven adaptations, quality indicators, and patient outcomes. Gynecol Oncol. 2022;164(2):370\u20138.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"4292_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/ijc.33689","volume":"149","author":"N Dereje","year":"2021","unstructured":"Dereje N, Addissie A, Worku A, Gebremariam A, Kantelhardt EJ, Assefa M, et al. Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in Addis Ababa, Ethiopia. Int J Cancer. 2021;149(6):1284\u20139.","journal-title":"Int J Cancer"},{"key":"4292_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100784","volume":"37","author":"JM Mumba","year":"2021","unstructured":"Mumba JM, Kasonka L, Owiti OB, Andrew J, Lubeya MK, Lukama L, et al. Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia. Gynecol Oncol Rep. 2021;37:100784.","journal-title":"Gynecol Oncol Rep"},{"issue":"7","key":"4292_CR50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1634\/theoncologist.2013-0326","volume":"19","author":"EJ Kantelhardt","year":"2014","unstructured":"Kantelhardt EJ, Moelle U, Begoihn M, Addissie A, Trocchi P, Yonas B, et al. Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy. Oncologist. 2014;19(7):727\u201334.","journal-title":"Oncologist"},{"issue":"17","key":"4292_CR51","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1016\/S0959-8049(00)00346-4","volume":"36","author":"F Levi","year":"2000","unstructured":"Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer. 2000;36(17):2266\u201371.","journal-title":"Eur J Cancer"},{"issue":"10197","key":"4292_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N, Brisson M. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497\u2013509.","journal-title":"Lancet"},{"issue":"10224","key":"4292_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575\u201390.","journal-title":"Lancet"},{"issue":"10224","key":"4292_CR54","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","volume":"395","author":"K Canfell","year":"2020","unstructured":"Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591\u2013603.","journal-title":"Lancet"},{"issue":"3","key":"4292_CR55","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1470-2045(18)30836-2","volume":"20","author":"KT Simms","year":"2019","unstructured":"Simms KT, Steinberg J, Caruana M, Smith MA, Lew JB, Soerjomataram I, et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020\u201399: a modelling study. Lancet Oncol. 2019;20(3):394\u2013407.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4292_CR56","first-page":"503","volume":"24","author":"AD Mwaka","year":"2015","unstructured":"Mwaka AD, Okello ES, Orach CG. Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda. Eur J Cancer Care (Engl). 2015;24(4):503\u201313.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"4292_CR57","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1200\/JGO.2016.006353","volume":"3","author":"S Grover","year":"2017","unstructured":"Grover S, Chiyapo SP, Puri P, Narasimhamurthy M, Gaolebale BE, Tapela N, et al. Multidisciplinary gynecologic oncology clinic in Botswana: a model for multidisciplinary oncology care in low- and middle-income settings. J Glob Oncol. 2017;3(5):666\u201370.","journal-title":"J Glob Oncol"},{"key":"4292_CR58","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2020.1097","volume":"14","author":"N Tumba","year":"2020","unstructured":"Tumba N, Adewuyi SA, Eguzo K, Adenipekun A, Oyesegun R. Radiotherapy waiting time in Northern Nigeria: experience from a resource-limited setting. Ecancermedicalscience. 2020;14:1097.","journal-title":"Ecancermedicalscience"},{"issue":"5","key":"4292_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4954","volume":"3","author":"KM Doll","year":"2020","unstructured":"Doll KM, Hempstead B, Alson J, Sage L, Lavallee D. Assessment of prediagnostic experiences of Black women with endometrial cancer in the United States. JAMA Netw Open. 2020;3(5):e204954.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"4292_CR60","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ygyno.2021.11.010","volume":"164","author":"KM Doll","year":"2022","unstructured":"Doll KM, Nguyen A, Alson JG. A conceptual model of vulnerability to care delay among women at risk for endometrial cancer. Gynecol Oncol. 2022;164(2):318\u201324.","journal-title":"Gynecol Oncol"},{"issue":"9211","key":"4292_CR61","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0140-6736(05)74722-X","volume":"355","author":"G Bodeker","year":"2000","unstructured":"Bodeker G, Kabatesi D, King R, Homsy J. A regional task force on traditional medicine and AIDS. Lancet. 2000;355(9211):1284.","journal-title":"Lancet"},{"issue":"1","key":"4292_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-020-01371-5","volume":"20","author":"N Dowhaniuk","year":"2021","unstructured":"Dowhaniuk N. Exploring country-wide equitable government health care facility access in Uganda. Int J Equity Health. 2021;20(1):38.","journal-title":"Int J Equity Health"},{"issue":"4","key":"4292_CR63","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10461-005-9019-9","volume":"9","author":"A Ssali","year":"2005","unstructured":"Ssali A, Butler LM, Kabatesi D, King R, Namugenyi A, Kamya MR, et al. Traditional healers for HIV\/AIDS prevention and family planning, Kiboga District, Uganda: evaluation of a program to improve practices. AIDS Behav. 2005;9(4):485\u201393.","journal-title":"AIDS Behav"},{"issue":"1","key":"4292_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3063-4","volume":"18","author":"A Akol","year":"2018","unstructured":"Akol A, Moland KM, Babirye JN, Engebretsen IMS. We are like co-wives\": Traditional healers\u2019 views on collaborating with the formal Child and Adolescent Mental Health System in Uganda. BMC Health Serv Res. 2018;18(1):258.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"4292_CR65","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.trstmh.2008.04.023","volume":"102","author":"SN Kiwanuka","year":"2008","unstructured":"Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters D, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. 2008;102(11):1067\u201374.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4292_CR66","unstructured":"Beaulieu N BD, Bloom R, Stein R. Breakaway: the global burden of cancer - challenges and opportunities. A report from the Economist Inteligence Unit. 2009."},{"key":"4292_CR67","unstructured":"Institute of Medicine Committee on Cancer Control in L, Middle-Income C. The National Academies Collection: Reports funded by National Institutes of Health. In: Sloan FA, Gelband H, editors. Cancer Control Opportunities in Low- and Middle-Income Countries. Washington (DC): National Academies Press (US) National Academy of Sciences.; 2007."},{"issue":"1","key":"4292_CR68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ygyno.2017.12.010","volume":"149","author":"SJ Ramey","year":"2018","unstructured":"Ramey SJ, Asher D, Kwon D, Ahmed AA, Wolfson AH, Yechieli R, et al. Delays in definitive cervical cancer treatment: an analysis of disparities and overall survival impact. Gynecol Oncol. 2018;149(1):53\u201362.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04292-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:12:42Z","timestamp":1781633562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04292-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5467551\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by institutional review boards at MNRH (MREC Protocol 1058), UCI (ER-007) and UCSF (16\u201321306). Uganda\u2019s national review board, UNCST, also reviewed and approved the research (HS29ES). All participants provided written informed consent. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}